nicotine has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, B; Ding, Y; Gonzalez, FJ; Jiang, C; Krausz, KW; Li, Y; Lin, J; Luo, Y; Nie, Q; Shen, Z; Sun, L; Wang, K; Wang, P; Wu, Q; Xia, J; Xu, F; Xue, Y; Yin, L; Yu, C; Zeng, G; Zhang, Z; Zheng, MH; Zheng, R | 1 |
| Byrne, CD; Miao, L; Targher, G; Zheng, MH | 1 |
| Hu, H; Lan, K; Liu, H | 1 |
| Fukuzawa, Y; Inoue, T; Ishii, N; Ito, K; Kanamori, H; Kobayashi, Y; Nakade, Y; Nakao, H; Ohashi, T; Sakamoto, K; Sumida, Y; Yamamoto, T; Yamauchi, T; Yoneda, M | 1 |
| Diéguez, C; Fernø, J; López, M; Martínez de Morentin, PB; Nogueiras, R; Seoane-Collazo, P | 1 |
| Chen, XM; Ding, YP; Li, FQ; Liu, YC; Tang, CL; Tong, XJ; Zhou, Z | 1 |
| Chen, XM; Li, FQ; Tang, CL; Wu, XC; Yan, S | 1 |
7 other study(ies) available for nicotine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.
Topics: AMP-Activated Protein Kinases; Animals; Bacteria; Ceramides; Disease Progression; Humans; Intestines; Mice; Nicotine; Non-alcoholic Fatty Liver Disease; Sphingomyelin Phosphodiesterase; Tobacco Smoking | 2022 |
The gut microbiome and nicotine metabolism in NAFLD.
Topics: Dysbiosis; Gastrointestinal Microbiome; Humans; Nicotine; Non-alcoholic Fatty Liver Disease | 2023 |
Human symbiont Bacteroides xylanisolvens attenuates NASH through intestinal nicotine catabolism.
Topics: Bacteroides; Humans; Nicotine; Non-alcoholic Fatty Liver Disease | 2023 |
Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
Topics: Amino Acids; Animals; Choline Deficiency; Male; Nicotine; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar | 2017 |
Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats.
Topics: Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Appetite Depressants; Appetite Regulation; Diet, Fat-Restricted; Diet, High-Fat; Dyslipidemias; Endoplasmic Reticulum Stress; Fatty Liver; Hyperinsulinism; Hypothalamus; Injections, Subcutaneous; Liver; Male; Nicotine; Nicotinic Agonists; Non-alcoholic Fatty Liver Disease; Obesity; Rats; Rats, Sprague-Dawley; Thermogenesis; Weight Loss | 2014 |
Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cell Line; Diet, High-Fat; Inflammation; Interleukin-6; Liver; Male; Mice; NF-kappa B; Nicotine; Nicotinic Agonists; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2015 |
[Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Diet, Carbohydrate Loading; Diet, High-Fat; Dietary Fats; Disease Models, Animal; Down-Regulation; Fructose; Inflammation; Interleukin-6; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nicotine; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2016 |